Mass vaccination campaigns have drastically reduced the burden of infectious diseases. Unfortunately, in recent years several infectious diseases have re-emerged. Pertussis poses a well-known example. Inspired by pertussis, we study, by means of an epidemic model, the population and evolutionary dynamics of a pathogen population under the pressure of vaccination. A distinction is made between infection in immunologically naive individuals (primary infection) and infection in individuals whose immune system has been primed by vaccination or infection (secondary infection). The results show that (i) vaccination with an imperfect vaccine may not succeed in reducing the infection pressure if the transmissibility of secondary infections is higher than that of primary infections; (ii) pathogen strains that are able to evade the immunity induced by vaccination can only spread if escape mutants incur no or only a modest fitness cost and (iii) the direction of evolution depends crucially on the distribution of the different types of susceptibles in the population. We discuss the implications of these results for the design and use of vaccines that provide temporary immunity.
INTRODUCTION
The twentieth century has witnessed the enormous success of vaccination campaigns against infectious diseases. This prompted optimism in the 1970s that a decisive victory in the battle against infectious diseases would be within reach. Alas, except for smallpox, eradication has not been achieved for any infectious disease, and in recent years the incidences of several infectious diseases show an increasing trend (see Cohen (2000) for a review).
An example of such a re-emerging infectious disease is pertussis or whooping cough. Before the introduction of mass vaccination, pertussis was one of the main causes of infant mortality, causing more deaths than all other infectious diseases of childhood taken together. Mass vaccination campaigns, started in the 1940s and 1950s, have led to a drastic reduction of the morbidity and mortality rates, and also have greatly reduced the level of circulation of Bordetella pertussis (Rohani et al. 2000) . Unfortunately, in the last decade it has become clear that what was once thought to be an infectious disease under the firm control of vaccination is now a re-emerging problem in developed countries (von Kö nig et al. 2002; .
To illustrate this, figure 1 (top panel) shows the yearly number of reported cases of pertussis in the Netherlands over the years [1993] [1994] [1995] [1996] [1997] [1998] [1999] [2000] [2001] . The panel shows a strong increase in the number of cases since 1995. Interestingly, the increase in the number of reported cases is largely due to an increase in the incidence in vaccinated children, adolescents and adults. This is exemplified by figure 1 (bottom panel), which shows the estimated incidence in vaccinated and unvaccinated children aged 5-9 years. This panel shows that, although the incidence in unvaccinated children (ca 4% of the population) has increased considerably since 1995, the incidence in vaccinated children (ca 96% of the population) has increased much more strongly. As a result, the incidences in the vaccinated and unvaccinated cohorts are at present not significantly different.
Furthermore, the true incidence of pertussis infections may be more than an order of magnitude higher than the incidence based on notification data, as most infections in adolescents and adults are subclinical and, therefore, go unnoticed (van Boven et al. 2004 and references therein) . In view of this, B. pertussis is increasingly recognized not only as an infection of infants, but also as an infection of children, adolescents and adults (e.g. Mink et al. 1992; Schmitt-Grohé et al. 1995; Wright et al. 1995; Nennig et al. 1996; Birkebaek et al. 1999; Senzilet et al. 2001; Strebel et al. 2001; Gilberg et al. 2002; see von Kö nig et al. (2002) for an overview). In fact, a recent estimate from the Netherlands suggests that the attack rate in the adult population is between 4 and 10% per year (Teunis et al. 2002) .
The question arises as to why pertussis is increasing. Could this be a population dynamic phenomenon? Or is it due to changes in the pathogen population, i.e. has adaptation of the pathogen played a role? In most developed countries the composition and quality of the vaccines generally have remained constant over time, thereby excluding the possibility that the recent increases are due to defective vaccines (see van Loo et al. 1999; van Loo & Mooi 2002; von Kö nig et al. 2002; van Boven et al. 2000 . It is also known that vaccines do not prevent infection for life (von Kö nig et al. 2002) , and that in recent years, the fraction of infections in vaccinated individuals has increased steadily.
Recent molecular studies have resulted in a wealth of genetic data, and offer the potential to greatly improve our understanding of the genes and regulatory pathways involved in determining pathogen virulence (e.g. Smith et al. 2001; Parkhill et al. 2003) . In fact, genetic studies have already revealed that populations of B. pertussis evolve by two different mechanisms. (i) The pathogen can evolve by changing its level of expression of virulence genes. As a consequence, it may become less visible to the host's immune system (in case of lowered expression) or become more efficient in colonizing the host (in case of increased expression; e.g. Cotter & DiRita 2000; Yuk et al. 2000) . (ii) Polymorphisms can evolve in the epitopes of major virulence genes that hinder recognition of the pathogen by the host's immune system after vaccination (e.g. Mooi et al. 1998 Mooi et al. , 1999 Mooi et al. , 2001 van Loo et al. 1999; Cassiday et al. 2000; van Loo & Mooi 2002; Hijnen 2004) .
The aim of this paper is twofold. First, we study the population dynamical consequences of mass vaccination, paying special attention to secondary infections. The population dynamical analysis sets the stage for the ensuing evolutionary analyses. We model two mechanisms of pathogen adaptation. In our first scenario, we assume that there is a trade-off between the efficiency of the pathogen in colonizing primary and secondary susceptibles, corresponding to the first evolutionary mechanism mentioned above. In the second scenario, there is a tradeoff between the susceptibility of vaccinated individuals and the duration of the infectious period, corresponding to the second evolutionary mechanism mentioned above.
POPULATION DYNAMICS
How does the incidence of primary and secondary infection depend on the vaccination coverage (the fraction of the population that is vaccinated) and the transmissibility of primary and secondary infection? The epidemic model presented in figure 2 and Electronic Appendix A forms the basis of our reasoning. In a pathogen-free population, the pathogen can invade if the so-called reproduction ratio exceeds one (Diekmann & Heesterbeek 2000) . The reproduction ratio is given by
where the subscript p stresses the dependence of the reproduction ratio on the vaccination coverage (Electronic Appendix A). The critical vaccination fraction p c to achieve herd immunity is easily obtained by putting pZp c in equation (2.1) and solving the equation for R p Z1. Equation (2.1) indicates that eradication is not always feasible when vaccinating with an imperfect vaccine (McLean 1999 (McLean , 2002 Gandon et al. 2003) . It is possible that the reproduction ratio increases with increasing vaccination coverage. In fact, if we assume for a moment that the infectious period of primary infection equals the infectious period of secondary infection (a 2 Za 1 ) this will happen if
Hence, vaccination increases the reproduction ratio if the transmissibility of secondary infections is sufficiently higher than that of primary infections, or if secondary susceptible individuals are sufficiently more susceptible than primary susceptibles. Consequently, the reproduction ratio may be smaller than one in an unvaccinated population but higher than one in a vaccinated population (Hethcote & Li 1999; Greenhalgh et al. 2000; Medley et al. 2001) .
Note that for realistic parameter values equation (2.2) may be satisfied even if primary infections are only slightly more transmissible than secondary infections. In fact, g 2 Z g 1 Z1, g V Z0, s V Z0.2 yr K1 and mZ0.013 yr K1 in the default parameter setting so that the reproduction ratio increases by vaccination if the transmissibility of secondary infections is just 7% higher than the transmissibility of primary infections.
The results of the equilibrium analyses are summarized by figure 3 (see Electronic Appendix A for details). The figure illustrates that, in general, the incidence of primary infection is much lower in a vaccinated than in an unvaccinated population. The reason is that only a small fraction of the population is available for primary infection in a vaccinated population. Figure 3 furthermore shows that the incidences of both primary and secondary infection decrease with increasing vaccination coverage if primary infections have higher transmissibility than secondary infections (i.e. f 1 Of 2 ). In this case, vaccination is always beneficial because it reduces the fraction of individuals available for primary infection, as well as the infection pressure. Hence, vaccination not only has a direct protective effect to those who are vaccinated, but it also reduces the probability of infection for those who are not vaccinated.
However, primary infections need not necessarily be more transmissible than secondary infections. In fact, primary infections occur most often in infants and young children, and usually lead to severe disease. This results in measures that decrease infectiousness such as isolation and antibiotic treatment. Secondary infections, on the other hand, are found mostly in adolescents and adults, and often go unnoticed. It is therefore plausible that in effect, asymptomatic secondary infections have higher transmissibility than primary infections, as secondary infected individuals will be more actively spreading the pathogen than primary infected individuals.
The consequences are profound. If secondary infections are sufficiently more transmissible than primary infections, vaccination may hamper rather than aid elimination of the pathogen. The intuitive explanation is that the effect of vaccination is to shift individuals to the class of secondary susceptibles where they are prone to highly transmissible secondary infection. As a result, vaccination may have the unpleasant consequence of increasing the infection pressure in the population. This implies that unvaccinated individuals in a vaccinated population may be at a higher risk of contracting a primary infection than individuals in an unvaccinated population. Moreover, they also may be infected at a younger age.
To give an example, let us set the transmissibility of primary and secondary infection at f 1 Z10 yr K1 and f 2 Z 100 yr K1 , and keep all other parameters at their default values (table 1). The probability that an unvaccinated individual escapes primary infection is given by m/(h*Cm), where m denotes the mortality rate and h* the equilibrium force of infection (e.g. Diekmann & Heesterbeek 2000) . In an equilibrium state the probability of escaping infection is 4.6% in an unvaccinated population, while it is only 4.0% in a vaccinated population. The average age at primary infection is given by 1/(h*Cm). Hence, the average age at infection is 3.5 years in an unvaccinated population and 3.1 years in a vaccinated population. Since age at infection is negatively correlated with the occurrence and severity of complications (e.g. von Kö nig et al. 2002) , vaccination may increase the number of primary infections with severe complications as it increases the probability of infection and decreases the age at infection.
Summarizing, although for pertussis there are undeniable benefits of mass vaccination in preventing infections with severe complications, there also is an important Figure 2 . Model structure. Individuals are classified as primary or secondary susceptible (S 1 and S 2 ), primary or secondary infected (I 1 and I 2 ), vaccinated ( V ) or recovered and immune (R). Notice that we have assumed g V Z0 in the population dynamical analysis.
caveat: even in the absence of an evolutionary response by the pathogen, a vaccination campaign may not succeed in reducing the incidence of infection if the immunity conferred by vaccination is temporary and if secondary infections are in effect more transmissible than primary infections. As we have argued, this is not unlikely for pertussis.
PATHOGEN ADAPTATION
Inspired by pertussis, we consider two different scenarios of pathogen adaptation. First, adaptation to vaccination may occur by altering the expression levels of virulence genes (adherence molecules, toxins). Second, mutations in the (epitopes of the) virulence genes may cause the bacterium to escape from the immunity in the population induced by vaccination. Figure 4 gives a schematic of the two kinds of pathogen adaptation.
(a) Virulence gene expression Will vaccination select for highly virulent pathogens that efficiently colonize and exploit unvaccinated susceptible hosts, and in doing so may cause considerable damage? Or does it select for relatively avirulent pathogens that are less efficient and do not inflict much damage? Recent theory predicts that certain types of vaccines are expected to increase virulence of the pathogen population so that unvaccinated susceptible individuals are exploited more efficiently and suffer more from the negative consequences of infection (Gandon et al. 2001 ). Here we ask whether similar phenomena occur if immunity against infection is temporary. Throughout, we equate virulence with the efficiency of the pathogen to infect and exploit primary susceptibles. Hence, it is measured by the parameter f 1 and it does not take into account pathogen-induced host mortality (which, on the population level, is negligible in case of pertussis in developed countries). Notice that our definition of virulence differs from definitions used in other modelling studies (e.g. van Baalen 1998; Gandon et al. 2001 Gandon et al. , 2003 Day & Burns 2003) . We refer to Casadevall & Pirofski (1999) for a detailed account of the different faces and definitions of virulence.
The idea that there may be differences between strains in their ability to exploit susceptible hosts, and that there is a systematic relation between the efficiency to colonize and exploit primary and secondary susceptibles, is not hypothetical. In fact, it is conceivable that B. pertussis strains can increase their efficiency in colonizing immunologically naive hosts by an increase in the expression of surface proteins involved in adherence to host tissue (e.g. pertactin), or by an increase in the expression in the toxins involved in the suppression of the immune response of the host (e.g. pertussis toxin). At the same time, however, an increased expression of these proteins facilitates the recognition of the pathogens by the immune system of the host (Cotter & DiRita 2000; Yuk et al. 2000) . In addition, the production of virulence molecules must impose an energetic cost making it unlikely that maximal expression of these genes is profitable.
Electronic Appendix B gives an outline of the analyses. In short, we have calculated the growth rates of a spectrum of mutant strains in a population in which a resident strain is present. Mutants with a positive growth rate will increase in frequency and successfully invade, while mutants with a negative growth rate cannot invade. Combinations of mutant parameter values that yield a zero growth rate represent, from an evolutionary point of view, strategies that are equivalent to the prevailing resident strategy. We focus on such strategies where the benefits of increased virulence (higher transmissibility from primary infecteds) are exactly balanced by the costs due to a lower transmissibility from secondary infecteds. The value of an increase in f 1 (virulence) in terms of an evolutionarily equivalent change in f 2 is given by
where for simplicity we have set g V Z0 (see Electronic Appendix B for general derivation). Equation (3.1) shows that the value of a change in the transmissibility of primary infection (i.e. f 1 ) in terms of an equivalent change in the transmissibility of secondary infection (i.e. f 2 ) is completely determined by the number of primary susceptibles per secondary susceptible in the resident population. Parameter values are f 2 Z25 (black lines) or f 2 Z100 (grey lines), with f 1 Z50. In both panels, incidence is calculated as the prevalence at equilibrium (see Electronic Appendix A) divided by the infectious period (1/(aCm)). Figure 5 gives a graphical overview of the results. In an unvaccinated population (top panel), the value of an increase in f 1 in terms of an equivalent decrease in f 2 is almost independent of the transmissibility of secondary infection if the transmissibility of primary infection is high ( f 1 Z250 yr
K1
). The intuitive explanation is that primary susceptible individuals will be infected quickly anyway, while the distribution of primary and secondary susceptible hardly depends on the transmissibility of secondary infection. If, on the other hand, the transmissibility of primary infection is low ( f 1 Z1 yr K1 ), the pathogen cannot persist if the transmissibility of secondary infection drops below a certain threshold value. For values of f 2 just above the threshold value the infection pressure in the population is very low and secondary susceptibles are almost absent. As a result, a small decrease in the transmissibility of primary infection f 1 is equivalent to a large increase in the transmissibility of secondary infection f 2 .
In a population with high vaccination coverage (figure 5, bottom panel) the value of an increase in the transmissibility of primary infection is hardly affected by the transmissibility of primary and secondary infection if the transmissibility of secondary infection is high enough (say f 2 O50 yr K1 ). Here, the intuitive explanation is that most individuals are rapidly shifted to the class of secondary susceptibles by vaccination. In this case, a certain increase in the transmissibility of primary infection is, from an evolutionary perspective, equivalent to a very small decrease in the transmissibility of secondary infection. If the transmissibility of secondary infection is very low the pathogen has difficulties persisting. As a consequence, a small increase in the transmissibility of primary infection is equivalent to a large decrease in the transmissibility of secondary infection.
To illustrate the above general results we consider a specific example. In the example, the relation between f 2 and f 1 is given by the following trade-off function
ða; bO 0; 0% f 1 % ffiffiffiffiffiffi ffi b=a p Þ. Using equations (3.1) and (3.2) the evolutionarily stable strategies (ESSs) can be located (Metz 1992; Dieckmann 2002; van Boven & Weissing 2004) . Figure 6 shows the relation between the vaccination coverage ( p) and the evolutionarily stable (ES) level of primary and secondary transmissibility (top panel) and the corresponding ES incidence of primary and secondary infection (bottom panel). In the figure, f 1 and f 2 are both able to evolve to values in the range 0-250. The top panel of figure 6 corroborates our argument that, from an evolutionary perspective, f 2 is more important than f 1 . In fact, f 2 evolves to values near its maximum while f 1 evolves to low values ( f 1 * !50). Figure 6 also shows that both the reproduction ratio and the incidence of secondary infection increase with increasing vaccination coverage, while the incidence of primary infection decreases from 1.3% per year in an unvaccinated population to 0% in a completely vaccinated population.
We conclude that whether selection favours virulent or avirulent pathogen strains depends to a large extent on the distribution of the various types of susceptible individuals in the population. Secondary susceptibles prevail for a broad range of parameter constellations. Therefore, the main selection pressure on the pathogen population will be to efficiently colonize and exploit secondary susceptibles. As a consequence, highly virulent strains that efficiently exploit primary susceptibles can only spread in the population if in doing so they are not hampered in their efficiency to infect secondary susceptibles. (b) Immune evasion A natural infection with B. pertussis induces long-lasting immunity in its host. As a consequence, there is a strong selection pressure on the pathogen to evade the immunity induced by prior infection. As a result, the pathogen population is expected to become highly polymorphic (May & Anderson 1983) . This early theoretical prediction is corroborated by a suite of subsequent studies (Gomes et al. 2002 and references therein) . In a vaccinated population there also is selection on the pathogen to evade the immune responses elicited by the vaccine. In fact, a mutant strain that is able to infect a certain fraction of the vaccinated individuals not available to a resident strain and that is otherwise identical has a selective advantage, and can always invade. Here we explore, by means of a simple model, how differences between a resident and mutant strain affect the mutant strain's invasion prospects. Specifically, we focus on a mutant strain for which the vaccine is less effective, and we assume that individuals in the vaccinated compartment (V ) can still be infected by the mutant strain. At the same time, however, the mutant strain is less fit as it induces a shorter infectious period.
A straightforward calculation (see Electronic Appendix B for methodology) shows that, at an ESS, the marginal value equation where the costs of a reduced infectious period exactly balances the benefits due to the possibility of direct infection of individuals in compartment V is given by
Equation (3.3) shows that the success of a mutant strain is closely related to the vaccination coverage ( p), the transmissibility of secondary infection ( f 2 ), and to the probability that a vaccinated individual will die before it loses its protection against infection ðm=ðmC s V C g V h½g V ÞÞ. In fact, the mutant's invasion prospects increase as the vaccination coverage or the protected period after vaccination increases, because then a large fraction of the population is in compartment V.
To give an example, take the default parameter setting (table 1) with f 2 Z50. For these parameter values the righthand side of equation (2.1) equals 2.93 yr
. This means that a mutant against which vaccination provides no protection at all still has to maintain an infectious period of at least ð1=ð25C 0:013C 2:93ÞÞ365Z 13:1 days if it is to invade a population where a resident strain with infectious period of ð1=ð25C 0:013ÞÞ365Z 14:6 days is present. If the protected period after vaccination is 10 years instead of 5 years (s V Z0.1), the mutant can invade if the infectious period is at least 11.9 days. Hence, even a mutant strain that is able to completely avoid the immunity induced by vaccination can only invade if its infectious period is only a couple of days shorter than the infectious period of the resident strain.
The empirical data on pertussis strongly suggest that vaccination has indeed selected for strains that are, to a certain extent, able to circumvent the immunity induced by vaccination (Mooi et al. 1998 ; van Loo 1999; King et al. 2001; van Loo & Mooi 2002) . For instance, the allelic variants of the pertactin and the pertussis toxin subunit 1 genes that match the Dutch vaccine were the predominant alleles in the early days of mass vaccination. Nowadays, the frequencies of these alleles have decreased to very low values, or have even disappeared altogether. Taken together, the third message is that the invasion prospects of a rare mutant strain increase as the vaccination coverage or the period of protection after vaccination increase. However, for realistic parameter values the fitness cost of such escape mutants in terms of, for instance, a reduction in the infectious period cannot be large.
DISCUSSION
We have shown that vaccination with an imperfect vaccine can have a number of counterintuitive implications. First, it may increase the level of circulation of a pathogen. As a result, elimination of the pathogen may prove more difficult in a vaccinated than in an unvaccinated population. Moreover, susceptible unvaccinated individuals in a vaccinated population may be exposed to a higher infection pressure than susceptible individuals in an unvaccinated population, thereby increasing the probability of infection and decreasing the average age at infection. Since in pertussis the age at infection is negatively correlated with the severity of disease, vaccination may increase the number of infections and complications in unvaccinated individuals.
Second, whether vaccination will select for high levels of virulence depends on the relative ability of pathogens to infect and exploit primary and secondary susceptibles. In general, a mutant pathogen strain with increased virulence (i.e. increased transmissibility of primary infection) will only successfully invade if it does not or only slightly reduces the transmissibility of secondary infection. The intuitive reason is that in a vaccinated population primary susceptibles constitute only a small fraction of the total host population (less than 5% in The Netherlands) while secondary susceptibles abound. Hence, the main selection pressure on the pathogen population will be to efficiently infect and exploit secondary susceptibles.
Third, the pathogen population may adapt to circumvent the immune responses elicited by the vaccine. In fact, mutant strains that are able to evade the immunity induced by vaccination or infection are selectively favoured. Hence, one could anticipate that the pathogen population will evolve to become highly polymorphic. However, this conclusion rests on the assumption that such mutant strains are intrinsically equally fit, or almost as fit as the resident strains. The fact that B. pertussis populations are relatively clonal could thus be taken as prima facie evidence that fitness differences between strains are not negligible. Alternatively, it could also indicate that population bottlenecks are common.
The fact that populations of B. pertussis may have evolved to circumvent the immune responses elicited by vaccination and to alter their virulence levels raises a number of questions concerning the design and use of future vaccines: which combination of antigens protects optimally against the circulating strains? How should one balance the breadth against the depth of a vaccine, i.e. should one include many polymorphic antigens or only a few monomorphic ones? Which vaccines, vaccination schemes and coverages minimize the probability of appearance of escape mutants? How does the evolutionary pressure on the pathogen population depend on the relationship between natural and vaccine-induced immunity? Should the aim of vaccination be to reduce symptomatic disease while maintaining circulation, or should it be to reduce virulence? Will vaccination select for aggressive virulent strains that efficiently exploit the host, or does it select for stealthy avirulent strains that are less visible to the immune system? Recent transitions from whole-cell vaccines comprising tens or perhaps even hundreds of antigens to subunit vaccines comprising far fewer antigens (one to five in the case of pertussis) have made the above questions pressing. Nevertheless, up to now, vaccine effectiveness studies almost invariably have focused on short-term effects in individual persons (immune responses, side-effects; e.g. Jefferson et al. 2003) . However, these studies cannot provide insight into the effect of vaccination on the level of circulation in the population, and into the long-term effects of vaccination. In view of our model results and the experimental evidence on pathogen adaptation, we believe that the design of vaccines should not only be focused on short-term individual responses, but it should take into account and anticipate the population dynamical and evolutionary consequences of vaccination as well.
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